MaxCyte, Inc. Foreign Currency Transaction Gain (Loss), before Tax
MaxCyte, Inc. (MXCT) reported Foreign Currency Transaction Gain (Loss), before Tax of -$67.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-13
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$67.00K, a 357.69% decline year-over-year.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$84.00K.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$66.00K.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$11.00K.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$70.00K.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$140.00K.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$84.00K.
- MaxCyte, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$79.00.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$67.00K 10-Q · filed 2026-08-13 | -$150.00K 10-Q · filed 2026-08-13 | -$217.00K derived: sum of 3 quarters · filed 2026-08-13 | -$228.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$84.00K 10-Q · filed 2026-05-13 | -$150.00K derived: sum of 2 quarters · filed 2026-05-13 | -$161.00K derived: sum of 3 quarters · filed 2026-05-13 | -$135.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$77.00K derived: sum of 2 quarters · filed 2026-03-25 | -$51.00K derived: sum of 3 quarters · filed 2026-08-13 | -$70.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$11.00K 10-Q · filed 2025-11-13 | $15.00K derived: sum of 2 quarters · filed 2026-08-13 | -$4.00K 10-Q · filed 2025-11-13 | -$82.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $26.00K 10-Q · filed 2026-08-13 | $7.00K 10-Q · filed 2026-08-13 | -$71.00K derived: sum of 3 quarters · filed 2026-08-13 | -$73.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$19.00K 10-Q · filed 2026-05-13 | -$97.00K derived: sum of 2 quarters · filed 2026-05-13 | -$99.00K derived: sum of 3 quarters · filed 2026-05-13 | -$126.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$80.00K derived: sum of 2 quarters · filed 2026-03-25 | -$107.00K derived: sum of 3 quarters · filed 2026-03-25 | -$140.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$2.00K 10-Q · filed 2025-11-13 | -$29.00K derived: sum of 2 quarters · filed 2025-11-13 | -$62.00K 10-Q · filed 2025-11-13 | -$80.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$27.00K 10-Q · filed 2025-08-06 | -$60.00K 10-Q · filed 2025-08-06 | -$78.00K derived: sum of 3 quarters · filed 2025-08-06 | -$114.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$33.00K 10-Q · filed 2025-05-08 | -$51.00K derived: sum of 2 quarters · filed 2025-05-08 | -$87.00K derived: sum of 3 quarters · filed 2025-05-08 | -$122.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$54.00K derived: sum of 2 quarters · filed 2025-03-11 | -$89.00K derived: sum of 3 quarters · filed 2025-03-11 | -$84.00K 10-K · filed 2025-03-11 | -$84.00 10-K · filed 2024-03-12 | |||
| 2023-09-30 | -$36.00K 10-Q · filed 2024-11-06 | -$36.50K 10-Q · filed 2023-11-08 | -$71.00K derived: sum of 2 quarters · filed 2024-11-06 | -$66.00K 10-Q · filed 2024-11-06 | -$65.50K 10-Q · filed 2023-11-08 | $16.62K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | -$35.00K 10-Q · filed 2024-08-06 | -$35.20K 10-Q · filed 2023-08-09 | -$29.00K 10-Q · filed 2024-08-06 | -$29.10K 10-Q · filed 2023-08-09 | $52.62K derived: sum of 3 quarters · filed 2024-08-06 | $31.02K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | -$6.10K 10-Q · filed 2023-05-10 | $87.62K derived: sum of 2 quarters · filed 2024-03-12 | $66.02K derived: sum of 3 quarters · filed 2024-03-12 | $17.12K derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-12-31 | $93.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $72.12K derived: sum of 2 quarters · filed 2024-03-12 | $23.22K derived: sum of 3 quarters · filed 2024-03-12 | -$79.00 10-K · filed 2024-03-12 | -$79.10K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | -$21.60K 10-Q · filed 2023-11-08 | -$70.50K derived: sum of 2 quarters · filed 2023-11-08 | -$93.80K 10-Q · filed 2023-11-08 | -$168.90K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$48.90K 10-Q · filed 2023-08-09 | -$72.20K 10-Q · filed 2023-08-09 | -$147.30K derived: sum of 3 quarters · filed 2023-08-09 | -$121.10K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $23.20K 10-Q · filed 2023-05-10 | -$23.20K 10-Q · filed 2022-05-09 | -$98.40K derived: sum of 2 quarters · filed 2023-05-10 | -$72.20K derived: sum of 3 quarters · filed 2023-05-10 | -$75.80K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$121.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$95.40K derived: sum of 2 quarters · filed 2023-03-15 | -$99.00K derived: sum of 3 quarters · filed 2023-03-15 | -$72.00K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $26.20K 10-Q · filed 2022-11-09 | $22.60K derived: sum of 2 quarters · filed 2022-11-09 | $49.60K 10-Q · filed 2022-11-09 | $161.60K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$3.60K 10-Q · filed 2022-08-10 | $3.60K 10-Q · filed 2021-09-13 | -$23.40K 10-Q · filed 2022-08-10 | $23.40K 10-Q · filed 2021-09-13 | $135.40K derived: sum of 3 quarters · filed 2022-08-10 | $81.20K derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $19.70K 10-Q · filed 2022-05-09 | $139.00K derived: sum of 2 quarters · filed 2022-05-09 | $84.80K derived: sum of 3 quarters · filed 2022-05-09 | $77.20K derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $119.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $65.10K derived: sum of 2 quarters · filed 2022-03-22 | $57.50K derived: sum of 3 quarters · filed 2022-03-22 | $81.80K 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | -$54.20K 10-Q · filed 2021-11-10 | -$61.80K derived: sum of 2 quarters · filed 2021-11-10 | -$37.50K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | -$7.60K 10-Q · filed 2021-09-13 | $16.70K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | -$24.70K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |